337 related articles for article (PubMed ID: 30352435)
21. Nosocomial pathogen biofilms on biomaterials: Different growth medium conditions and components of biofilms produced in vitro.
Solis-Velazquez OA; Gutiérrez-Lomelí M; Guerreo-Medina PJ; Rosas-García ML; Iñiguez-Moreno M; Avila-Novoa MG
J Microbiol Immunol Infect; 2021 Dec; 54(6):1038-1047. PubMed ID: 32680693
[TBL] [Abstract][Full Text] [Related]
22. Biofilm formation and disinfectant resistance of Salmonella sp. in mono- and dual-species with Pseudomonas aeruginosa.
Pang XY; Yang YS; Yuk HG
J Appl Microbiol; 2017 Sep; 123(3):651-660. PubMed ID: 28644912
[TBL] [Abstract][Full Text] [Related]
23. Differences in biofilm and planktonic cell mediated reduction of metalloid oxyanions.
Harrison JJ; Ceri H; Stremick C; Turner RJ
FEMS Microbiol Lett; 2004 Jun; 235(2):357-62. PubMed ID: 15183885
[TBL] [Abstract][Full Text] [Related]
24. Culture media profoundly affect Candida albicans and Candida tropicalis growth, adhesion and biofilm development.
Weerasekera MM; Wijesinghe GK; Jayarathna TA; Gunasekara CP; Fernando N; Kottegoda N; Samaranayake LP
Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):697-702. PubMed ID: 27706381
[TBL] [Abstract][Full Text] [Related]
25. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
26. Enhanced synergistic effects of xylitol and isothiazolones for inhibition of initial biofilm formation by Pseudomonas aeruginosa ATCC 9027 and Staphylococcus aureus ATCC 6538.
Zhou G; Peng H; Wang YS; Huang XM; Xie XB; Shi QS
J Oral Sci; 2019; 61(2):255-263. PubMed ID: 31217374
[TBL] [Abstract][Full Text] [Related]
27. A simple in vitro model for growth control of bacterial biofilms.
Hodgson AE; Nelson SM; Brown MR; Gilbert P
J Appl Bacteriol; 1995 Jul; 79(1):87-93. PubMed ID: 11419484
[TBL] [Abstract][Full Text] [Related]
28. The effects of hyperosmosis or high pH on a dual-species biofilm of Enterococcus faecalis and Pseudomonas aeruginosa: an in vitro study.
van der Waal SV; van der Sluis LW; Özok AR; Exterkate RA; van Marle J; Wesselink PR; de Soet JJ
Int Endod J; 2011 Dec; 44(12):1110-7. PubMed ID: 21859433
[TBL] [Abstract][Full Text] [Related]
29. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
30. Enteric Gram-negative bacilli suppress Candida biofilms on Foley urinary catheters.
Samaranayake YH; Bandara HM; Cheung BP; Yau JY; Yeung SK; Samaranayake LP
APMIS; 2014 Jan; 122(1):47-58. PubMed ID: 23656511
[TBL] [Abstract][Full Text] [Related]
31.
Yadav MK; Chae SW; Go YY; Im GJ; Song JJ
Front Cell Infect Microbiol; 2017; 7():125. PubMed ID: 28459043
[No Abstract] [Full Text] [Related]
32. [A novel nanoparticle in treatment of staphylococcus aureus and pseudomonas aeruginosa biofilms].
Huang SM; Zhao YL; Dong D; Zhang YQ; Geng J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 33(4):326-331. PubMed ID: 30970403
[No Abstract] [Full Text] [Related]
33. Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro.
Junka AF; Szymczyk P; Smutnicka D; Kos M; Smolina I; Bartoszewicz M; Chlebus E; Turniak M; Sedghizadeh PP
J Oral Maxillofac Surg; 2015 Mar; 73(3):451-64. PubMed ID: 25544303
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of different detection methods of biofilm formation in Staphylococcus aureus.
Knobloch JK; Horstkotte MA; Rohde H; Mack D
Med Microbiol Immunol; 2002 Oct; 191(2):101-6. PubMed ID: 12410349
[TBL] [Abstract][Full Text] [Related]
35. Immobilization of proteases on chitosan for the development of films with anti-biofilm properties.
Elchinger PH; Delattre C; Faure S; Roy O; Badel S; Bernardi T; Taillefumier C; Michaud P
Int J Biol Macromol; 2015 Jan; 72():1063-8. PubMed ID: 25451753
[TBL] [Abstract][Full Text] [Related]
36. Metabolic modeling of a chronic wound biofilm consortium predicts spatial partitioning of bacterial species.
Phalak P; Chen J; Carlson RP; Henson MA
BMC Syst Biol; 2016 Sep; 10(1):90. PubMed ID: 27604263
[TBL] [Abstract][Full Text] [Related]
37. Production of staphylococcal enterotoxin in mixed cultures.
Noleto AL; Malburg Júnior LM; Bergdoll MS
Appl Environ Microbiol; 1987 Oct; 53(10):2271-4. PubMed ID: 3122653
[TBL] [Abstract][Full Text] [Related]
38. Interactions between fish isolates Pseudomonas fluorescens and Staphylococcus aureus in dual-species biofilms and sensitivity to carvacrol.
Wang Y; Hong X; Liu J; Zhu J; Chen J
Food Microbiol; 2020 Oct; 91():103506. PubMed ID: 32539951
[TBL] [Abstract][Full Text] [Related]
39. [STUDY OF COLONIZATION PROCESSES AND PERSISTENCE OF MICROORGANISMS IN ARTIFICIAL MATERIALS FOR MEDICAL USE].
Didenko LV; Avtandilov GA; Smirnova TA; Shevlyagina NV; Tsarev VN; Lebedenko IY; Elinson VM; Tiganova IG; Romanova YM; Ippolitov OV
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):64-9. PubMed ID: 26829856
[TBL] [Abstract][Full Text] [Related]
40. Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
Drago L; De Vecchi E; Mattina R; Romanò CL
Int J Artif Organs; 2013 Jan; 36(1):39-46. PubMed ID: 23280076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
